Canopy Growth: Is There Budding Potential in the Cannabis Market?

Canopy Growth stock hit 52-week lows recently on news of needing to re-file on its BIoSteel business, so what now?

| More on:
Powder of Cannabis (Drugs), Analysis of Cannabis in laboratory.

Image source: Getty Images

Canopy Growth (TSX:WEED) may be one of the most undervalued stocks on the TSX today. Even in the cannabis sector, Canopy Growth stock simply continues to be beaten down by past performance. Or, to be frank, the instability of other cannabis stocks rather than its own performance of late.

Yet just because a stock should be valued higher doesn’t mean investors and financial institutions will see it that way. So let’s look at whether Canopy Growth stock is a great opportunity right now, or if investors should hold off.

Wa present profits

There were a lot of “one days” when it came to investing in Canopy Growth stock over the last few years. One day it would be the biggest producer in the world. One day it would provide cannabis to the country set to be the largest consumer, as in the United States. And, therefore, one day it could make you really rich!

However, what investors really want are right nows. In that sense, Canopy Growth stock shifted over the last few years. It made cuts from staff, closed locations, and severely cut back on research and development. Instead, it focused on profitable areas of revenue creation.

The company, in particular, looks to its BioSteel business to help fill this gap. However, the company came out with a statement on May 12 stating it would refile three of its past quarterly financial statements. Canopy Growth stock uncovered “material misstatements” linked to its BioSteel business.

This caused the company’s share price to drop to 52-week lows, but it’s unclear what those errors were. Therefore, investors do not have any idea as to what these numbers could be, or what could happen in the near future as the review continues.

What about Acreage?

There is a lot of dependency on BioSteel, and a lot of attention to it right now. However, what about the Acreage Holdings acquisition Canopy Growth stock went through last year? The company announced it would be going through with the purchase after the White House stated it would give a pardon to felony charges of simple marijuana possession.

The Acreage Holdings finalization isn’t likely to go through until the second half of 2023. And given the recent information, that might be pushed back even longer. And that might come as a relief to many investors who believe frankly that Canopy Growth stock cannot afford the US$3.4 billion purchase.

But, what if it can?

Future looking investors

If you’re hoping to buy now and hold for a significantly long period of time, Canopy Growth stock looks like a steal. Economists note that the marijuana industry continues to expand rapidly not just in Canada and the United States, but around the world. And not just recreationally, but medicinally as well.

Furthermore, the stock is so cheap. There is bound to be growth, with analysts pegging the consensus price target at about $3 as of writing. That could make shares double in price in just a year!

While Canopy Growth stock is down and could fall further from these re-filings, don’t count it out. If you’re interested in major growth in the next decade, then I would certainly consider picking up the stock. However, if you’re hoping for the riches we saw back in 2017, think again. It’s unlikely to happen for the next several years or more.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has positions in Canopy Growth. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Cannabis Stocks

Cannabis grows at a commercial farm.
Cannabis Stocks

What’s Happening With Cannabis Stocks in May 2023?

Cannabis stocks were up this week, as the market began to turn, but how long will it last, and is…

Read more »

Cannabis smoke
Cannabis Stocks

Are Cannabis Stocks a Good Buy in May 2023?

If you're going to buy cannabis stocks, these are pretty much the only two I would consider. Even so, you…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Aurora Cannabis: Time to Light Up Your Portfolio?

Here's my take on whether Aurora Cannabis (TSX:ACB) is worth adding to a growth portfolio right now, given its growth…

Read more »

Target. Stand out from the crowd
Tech Stocks

These Undervalued TSX Stocks Are a Bargain in May 2023

If you're willing to bet on a rebound, these are the three TSX stocks I would consider first as they…

Read more »

A cannabis plant grows.
Cannabis Stocks

Tilray Stock Is Scraping 52-Week Lows: Will it Bottom Out Soon?

Tilray (TSX:TLRY) stock remains down 53% in the last year, but when will this company hit the bottom and start…

Read more »

Medicinal research is conducted on cannabis.
Metals and Mining Stocks

2 Canadian Stocks That Are Simply Too Cheap to Avoid

These two Canadian stocks have sunk lower and lower, which is why now could be the right time for long-term…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

1 Marijuana Stock I’d Buy Over Aurora Cannabis

Explore a promising marijuana stock that outshines Aurora Cannabis. Unveil the investment opportunity to boost your cannabis portfolio.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

Is Canopy Growth Stock a Buy or a Sell in April 2023?

Canopy Growth stock is trading at a depressed valuation due to weak fundamentals. But does this make WEED stock a…

Read more »